I-CANVAX 2024: Innovative Cancer Vaccine Development
Global and Indian Synergies
December 12, 2024
Kolkata, India
Dr. John T. Schiller, PhD
Distinguished Investigator, National Cancer Institute
Dr. John Schiller is a world-renowned expert in virus-related cancers and the development of the the human papillomavirus (HPV) prophylactic vaccines that ultimately became the commercial vaccines Cervarix and Gardasil. His groundbreaking research at the National Cancer Institute has had a profound impact on cancer prevention, leading to the development of life-saving vaccines.
https://ccr.cancer.gov/staff-directory/john-t-schiller
Dr. Elad Sharon, MD, MPH
Senior Investigator, Harvard Medical School
Dr. Elad Sharon is a Senior Investigator at Harvard Medical School, where his work focuses on the clinical development of novel cancer therapies and immunotherapy. With a deep expertise in oncology, Dr. Sharon plays a pivotal role in advancing clinical trials and shaping the direction of cutting-edge cancer treatment strategies.
https://connects.catalyst.harvard.edu/Profiles/display/Person/64613
Dr. Chandan Guha, MBBS, PhD
Vice Chair and Professor, Department of Radiation Oncology, Albert Einstein College of Medicine
Dr. Chandan Guha is a renowned leader in radiation oncology and oncophysics, with extensive expertise in radiation-induced immune modulation and innovative cancer treatments. As the Director of the Einstein Institute of Oncophysics, Dr. Guha’s research focuses on integrating radiotherapy with immunotherapy to improve treatment outcomes for cancer patients.
https://einsteinmed.edu/faculty/7020/chandan-guha
Dr. Vivek Mittal, PhD
Professor of Cell and Developmental Biology in Radiation Oncology, Weill Cornell Medicine
Dr. Vivek Mittal is a distinguished researcher specializing in tumor microenvironment and cancer immunotherapy. His work at Weill Cornell Medicine explores how the microenvironment influences cancer progression and response to therapies, with a focus on integrating immune-based approaches with radiation therapy to improve cancer treatment outcomes.
https://vivo.weill.cornell.edu/display/cwid-vim2010
Dr. Angelika Riemer, PhD
Head of Cancer Immunoprevention, German Cancer Research Center (DKFZ)
Dr. Angelika Riemer is at the forefront of cancer immunoprevention research, particularly in the development of vaccines to prevent virus-induced cancers. Her work at DKFZ focuses on HPV-related cancer prevention, contributing significantly to global efforts in cancer immunotherapy.
https://www.dzif.de/en/angelika-riemer
Dr. Partha Basu, MD, PhD
Head, Screening Group, International Agency for Research on Cancer (IARC), France
Dr. Partha Basu is a leading global expert in cancer prevention, with a focus on cervical cancer screening and early detection in low-resource settings. His work at IARC is instrumental in developing and implementing large-scale cancer screening programs aimed at reducing the global cancer burden.
https://www.linkedin.com/in/partha-basu-ba169773
Dr. Thangarajan Rajkumar, MD, PhD
Senior Consultant, Molecular Oncology, Cancer Institute (WIA), Chennai, India
Dr. Thangarajan Rajkumar is a pioneer in molecular oncology and cancer genomics. He has made significant contributions to personalized cancer treatment, particularly in India, and continues to advance research in the molecular mechanisms of cancer and innovative therapeutic approaches.
https://www.alumnimmc.com/halloffame/dr-thangarajan-rajkumar/25
Dr. Sachet Shukla, PhD
Assistant Professor, Department of Genitourinary Medical Oncology, MD Anderson Cancer Center
Dr. Sachet Shukla specializes in the molecular biology of genitourinary cancers, focusing on prostate and bladder cancers. His research at MD Anderson Cancer Center aims to understand the molecular mechanisms of tumor resistance and to develop new therapeutic strategies for these cancers.
https://faculty.mdanderson.org/profiles/sachet_shukla.html
Dr. Anupama Goyal, PhD
Senior Scientist
Dr. Anupama Goyal is a Senior Scientist with expertise in pharmaceutical research, specializing in developing novel drug delivery systems and advanced therapies. With years of experience in research and development, she has made significant contributions to the pharmaceutical industry, focusing on improving therapeutic outcomes through innovative approaches.
https://www.linkedin.com/in/anupama-goyal-1955987b